(lp0
S'AcelRx Pharmaceuticals Presents Efficacy and Pharmacokinetics of DSUVIA at ... PR Newswire  - Mar 16, 2017 REDWOOD CITY, Calif., March 16, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...'
p1
aS'AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in March PR Newswire  - Mar 1, 2017 REDWOOD CITY, Calif., March 1, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of&nbsp;...AcelRx Pharmaceuticals Inc  Set to Announce Earnings on Thursday - Sports Perspectives'
p2
aS'AcelRx Pharmaceuticals, Inc. to Present at The MicroCap Conference on April ... Yahoo Finance - Mar 16, 2017 The MicroCap Conference will take place in New York City at the Essex House on April 4th. Registration will begin on Tuesday, April 4, at 7:00AM, and will last until the evening.'
p3
aS'AcelRx Pharmaceuticals to Hold Annual 2016 Financial Results Conference Call ... PR Newswire  - Feb 23, 2017 REDWOOD CITY, Calif., Feb. 23, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...'
p4
aS'AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results PR Newswire  - Mar 2, 2017 REDWOOD CITY, Calif., March 2, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain,&nbsp;...ACELRX PHARMACEUTICALS, INC.  Files An 8-K Other Events - Market Exclusive'
p5
aS'AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in ... Yahoo Finance - Mar 17, 2017 REDWOOD CITY, Calif., March 17, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...'
p6
aS'AcelRx Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 21 Equities.com - Mar 21, 2017 AcelRx Pharmaceuticals Inc.  traded on unusually high volume on Mar. 21, as the stock lost 3.28% to close at $2.95. On the day, AcelRx Pharmaceuticals Inc. saw 310,822 shares trade hands on 1,040 trades. Considering that the stock averages only a&nbsp;...Traders Actions to Focus: AcelRx Pharmaceuticals, Inc.  - Is stories'
p7
aS'AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer PR Newswire  - Feb 16, 2017 REDWOOD CITY, Calif., Feb. 16, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;...BRIEF-Acelrx Pharmaceuticals appoints Vincent Angotti as CEO - ReutersRecommended Mix Momentum Stocks: Facebook , AcelRx Pharmaceuticals ... - Street Wise Report '
p8
aS"Why AcelRx Pharmaceuticals Inc. Is Crashing Motley Fool - Mar 10, 2015 What's happening: Shares in AcelRx Pharmaceuticals  continued their decline today, falling by as much as 10% after the company reported disappointing fourth quarter results. The drop follows yesterday's 37% collapse on news that the FDA&nbsp;...AcelRx Pharmaceuticals  Stock Extends Losses Today as Jefferies Downgrades - TheStreet.com"
p9
aS"AcelRx Pharmaceuticals' ARX-04 Phase 3 Trial Met its Primary Endpoint, Reduced ... PR Newswire  - Aug 15, 2016 REDWOOD CITY, Calif., Aug. 15, 2016 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe&nbsp;..."
p10
a.